chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Upper left arm in area of injection was very sore and warm. I felt very warm (did not check to see if I had a fever) and had a scratchy throat. I took one 500mg acetaminophen before bed. Next day arm not as sore but throat still scratchy. Gargled w/mouthwash before bed. 10/12/16 could barely move my left upper arm since I was in such extreme pain in that arm that I could only move my lower arm as high as my waist. I used ice packs intermittently and took one acetaminophen in the morning and one before bed for 3 days with some improvement in mobility of my left upper arm after two days. Improvement continued each day and by day six 10/17/16 of this event. I had very good mobility in my left arm with only slight discomfort. On 10/19/16 I again could barely move my left arm without extreme pain. I used ice intermittently and had x-rays on 10/20/16 after calling my Dr's office. I had spoken with them twice during the week when this limited mobility of my left arm first began. 11/2/16 I had a lot of soreness in my left hip bone joint. This began approximately 11:00 am and I began experiencing difficulty walking due to extreme pain in my hip (left). By about 6pm that night I had to use a cane to walk and still had extreme pain in my left hip. The next day I was much better however about 3 days later I experienced pain in my right hip but have had no difficulty walking. I still have pain in my right hip.
79y.o. female with pmh of CKD stage 3 likely from DM/HTN nephropathy who presents with hyperkalemia. She was sent by PCP, Dr, who noted office labs with K 6.6. In EC, pt hemodynamically stable K was 5.8- she was given dextrose, insulin, kayexalate EKG with no significant changes She denies any chest pain, shortness of breath, palpitations, nausea, vomiting, fever or chills. Found to be COVID positive- asymptomatic  Deemed medically stable for discharge negative for any reversible ischemia.  PT OT evaluation and PMNR evaluation was done and recommended subacute rehab which was arranged on discharge.
This is a spontaneous report from a contactable consumer (patient). An 81-years-old male patient received bnt162b2 (COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 31Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunization. The patient medical history included lumbar problem. Concomitant medication included baclofen (BACLOFEN) taken for muscle relaxant therapy, start and stop date were not reported. The patient took the first bnt162b2 on 10Mar2021 in left arm for COVID-19 immunization and didn't feel anything. The second shot the patient took 21 days later, the first week the patient didn't feel anything but the second week, now the patient already suffered with lower back problem in the lumbar region of his back and since the patient took the second shot in the second week it seems like it got elevated that lower back problem from his back up to his neck and the patient was already taking a muscle relaxant tablet Baclofen 20 mg. It was supposed to relax muscle in his lower back/ lumbar region of his back. The first shot, it didn't affect the lower back but the second shot elevated the lumbar problem that the patient was having up to spine section of his back. The patient already had the lumbar problem but it seems like the second shot had elevated the pain up the whole back. The patient was having back problem with his whole back. The patient had taken the medication which was muscle relaxer and then the second shot had a muscle relaxer in it. The patient think that second shot was going to react with the bad numb body region that the patient had in his back and causing it to elevate up his back. The patient just feel that if you got a back problem the patient believed that the second shot seems like having a relaxer or something in it that would act with the tablet that you already were taking for the lumbar region of the back. The patient didn't have it going up his back, it was in one shot but now it went down the legs, the patient was having problem in his back. But the patient was concerned about the leg problem but since it was going up the back further than what the patient had at first. The patient had no problem with the first one. the patient think the first one was like 1 mg and the second one was 3 mg. 1 week from the date of shot. Around 06Apr2021 the patient began to have problem. Outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sore arms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arms) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 013A21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arms). At the time of the report, PAIN IN EXTREMITY (Sore arms) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
Information was received from a nurse, concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 30-MAY-2017 the patient was vaccinated with a expired dose of VAQTA (dose and route of administration were not provided) (lot # M031695, expiration date 26-MAY-2017) for prophylaxis. No adverse effects were reported. Additional information has been requested.
On 5/26/21, the day after receiving COVID-Pfizer vaccine #1, Patient has been urinating blood , experienced loss of appetite, weight loss, headaches and fatigue.  He is currently a patient at A medical center. His doctors' have completed blood work , urine samples , a CT scan , ultra sound and cystoscopy.
Mother of child called the immunization dept. the next morning and stated that the she noticed that the child had developed a rash from fingertips to elbows, bilaterally, and around her navel the evening of the immunizations. She administered Benadryl to her child.
Redness noted 7/26/04; harden area 7/20/04.
heart attack; chest pressure; hardly slept; This is a spontaneous report from a contactable consumer (patient's wife).  An 80-year-old male patient (reported also as 81-years-old, to be clarified) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EL3246), via an unspecified route of administration, on 13Jan2021 at single dose for COVID-19 immunisation. Age at vaccination was 80-years-old. Medical history included ongoing emphysema and ongoing diabetes (caller has been diagnosed for 35 years for both conditions), heart was damaged because of the diabetes, and a history of bypass 4 years ago however he hasn't had any issues with chest pressure since before the bypass. Concomitant medications were none. On 15Jan2021 at 1:am he developed pressure in the chest which ultimately resolved. This trouble last night, lasted over 1 hour. He couldn't get back to bed. He had to sleep sitting up on the sofa. That was the only way he was comfortable. Her husband has hardly slept. She was seeing how he was doing. He said he was okay sitting. The pressure on his chest would go away while he was sitting, but laying down it would come back. This morning (15Jan2021) she made him check when he woke up at 8 o'clock. She made him lay down, and he said it was gone after sitting the whole night. He is well now. He is feeling fine. He didn't even ask for help getting on his clothes. He got the vaccine because of his age and because of underlying conditions. Her husband has done very well this year. He even has underlying conditions. He has had Emphysema for 35 years, but it hasn't been bothering him. He has also had diabetes for 35 years. The reporter spoke to her husband's hcp (nurse) who said it could have a heart attack and for him to go to hospital if it reoccurs. She did speak with a nurse with his primary doctor, and she said the pressure in his chest for 1 hour could have been a heart attack. That if it occurs again to give him the nitroglycerin. She told the nurse it wasn't pain. The reporter stated chest pressure could have been a heart attack. He is scheduled to get the 2nd dose on 21Jan2021. The reporter was wondering if her husband can have the second dose given it has potassium in it (given he has bypass history). The reporter is afraid the vaccine is not safe, and they may not go for the second vaccine. She wants more information if it is safe.  The events recovered on 15Jan2021.
booster; diagnosed with covid-19 infection; diagnosed with covid-19 infection; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 42 year-old female patient received bnt162b2 (BNT162B2), administration date 10Dec2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "diagnosed with covid-19 infection". Therapeutic measures were taken as a result of covid-19. Clinical course: HCP states she has a 42 yr old female patient diagnosed with covid-19 infection and has been prescribed Paxlovid - states this patient has taken one days dose so far.  The lot number for bnt162b2 was not provided and will be requested during follow; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events and Immunization
No true adverse event; reporting due to 4th dose given before FDA approval (patient not moderate to severely immunocompromised)
patient received 2 doses of the flu vaccine when they should have only received one (they had two doses last year which was the first year). No reaction reported.
no adverse event; Patient administered pediatric monovalent vaccine instead of bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient administered pediatric monovalent vaccine instead of bivalent booster) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-Dec-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient administered pediatric monovalent vaccine instead of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient administered pediatric monovalent vaccine instead of bivalent booster) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient administered pediatric monovalent vaccine instead of bivalent booster).    This case contains information for the 11th of 16 adult patients described by the reporter. No concomitant product reported by reporter. No treatment medication reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-692175 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-692175 case
reporter indicated 2 or 3 pts remain non-responsive p/initial series of 3 doses of engerix-B followed by boosters;
Patient's recieved COVID vaccine for first dose and another manufacturer vaccine for second dose. No notable adverse events reported from shelter.
i have a ball under my left collar bone. I had covid symptoms friday night, chills fever etc then on saturday night i was fatigued low grade fever and body aches. on sunday when i woke up i felt it stressed and felt the ball.
Extreme muscle pain and shoulder pain in injection arm within 6 hours and into the evening.  Extreme unwell feeling at night.
local inflammation at injection site Left arm swelling, redness, pain and fatigue today after pneumonia shot today The incident occurred 3 to 6 hours ago. The incident occurred at home. Injury mechanism: received pneumococcal vaccine this morning. The pain is present in the left shoulder. The quality of the pain is described as aching. The pain radiates to the left arm. The pain has been worsening since the incident. Pertinent negatives include no chest pain, numbness or tingling. She has tried nothing for the symptoms.
Was feeling very fatigued and sinus pressure. Woke up with upset stomach around 6am. By Noon 12/07/09 had severe stomach pain and servere diarrhea. Temp is normal but feel warm. Left work early.
Type of Adverse Event: Abnormal bleeding/spotting Date of Adverse Event: Thursday, 4/15/2021-Thursday, 4/15/2021 (within the same day); less than 1 hour; duration of event approximately 3-5 minutes Treatment: None; self-monitor bleeding/symptoms Outcome: Bleeding stopped/disappeared without any treatment or invention  Other details: Patient (myself) had reported experience of a single occurrence of abnormal bleeding, minimal/very light spotting associated with in-between periods. Patient had first reported adverse event (side effect) to patient physician (OBGYN). The patient's physician (OBGYN) had advised the patient to report side effect/adverse event to the vaccination site/VAERS. Date of event had occurred exactly one week to the day of vaccination (first dose of vaccine). Abnormal bleeding/spotting in-between periods is extremely unusual and abnormal for the patient. Patient is not pregnant or breastfeeding. No patient use of medications/prescriptions/antibiotics/birth control/hormonal therapy/surgeries/injuries/drugs/alcohol.
pt developed right cervical lymphadenopathy within approx 4 days of first vaccine, pt seen in urgent care and decreased wbc count at 3.1.  pt followed up in clinic with pcm on 5/17/2021, lymph node was still swollen and u/s and repeat cbc collected.  WBC down to 2.96.   8/06/2021 pt reported lymph node had resolved, repeat CBC increased to 3.15.  Pt chose to continue with 2nd vaccine in the series, received on 8/23/2021, pt developed left sided lymphadenopathy, cervical chain approx 1 cm and supraclavicle approx 1 cm developed again in within 3-4 days. Pt reports she had a real dry and burning feeling in her nose for about 24 hours after the 2nd vaccine but otherwise not other symptoms until the lymph nodes enlarged a couple of days later
No additional AE reported; Office manager reports ROTATEQ was administered after a temperature excursion to 23 patients.; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were not provided.    On 15-JUL-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) once, (lot number W011279 has been verified to be a valid lot number, expiry date 02-NOV-2023) as prophylaxis (strength, dose, route of administration, and anatomical location, date were not provided) (product storage error).  The rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was stored at a temperature of 9 degree Celcius (C) for the time frame of 1 hour and 32 minutes. There was no previous temperature excursion.  No additional adverse events reported.  This is one of several reports received from the same reporter.
02/11/2022 I went for my yearly mammograms'. The doctor was concerned feeling larger lymph nodes. I had to have a 3D ultrasound. In February of 2023 I will go for another mammogram. My bloodwork for my thyroid has been abnormal. My numbers were down compared to previous bloodwork where they are trending up. I have not been prescribed any medications. My thyroid numbers are going back to normal. In November of 2021 I contracted COVID 19. I had a scratchy throat, aches, and cold like symptoms. I also lost my sense of taste and smell. The scratchy throat lasted 3-4 days. The cold like symptoms lasted about 3 weeks. The loss of senses came back after about 3 weeks.
Redness at injection site expanded to size of tennis ball, itching, and swelling to deltoid.
Feeling congestion and itching to arms and throat; Feeling congestion and itching to arms and throat; Feeling congestion and itching to arms and throat; This is a spontaneous report from a contactable Other HCP. A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: not reported, Expiry date: unknown) via intramuscular route of administration on 06Mar2021 15:00 (at the age of 23-years-old) as dose 1, single for COVID-19 immunization administered at Public Health Clinic/Veterans Administration facility. It was unknown if patient was pregnant at the time of vaccination. The patient other medical history was unknown. It was unknown if the patient had allergies to medications, food or other products. The patient concomitant medications were not reported. It was unknown If the patient was diagnosed with COVID-19 prior to vaccination. It was unknown since the vaccination, has the patient been tested for COVID-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine and list of any other medications the patient received within 2 weeks of vaccination. On 06Mar2021 15:00, the patient reported she was feeling congestion and itching to arms and throat. The reporter assessed the events as non-serious. The patient received Benadryl 50mg PO total. Patient was able to drink water without difficulty. Patient discharged home after 60 minutes of observation for the events. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
None Stated.  11/30/06 Received medical records from hospital which reveal patient was admitted 11/7/06 w/right sided numbness & tingling of arm, leg & cheek for 15 hours.  Migraine HA normal pattern was 1-2/month but since flu shot had increased to 2-3/week with one episode of difficulty with word finding & writing.  Patient improved with use of steroids. PT/OT/ST evals done. FINAL DX: left pontine lesion, cerebral infarction vs ADEM. 12/14/06 Received medical records from neuro which reveal patient initially evaluated 11/17/06.  Exam revealed: five finger dexterity exam was abnormal on right; decreased response to pain & temp on entire right side; impaired finger to nose movement on right; impaired balance with ataxic gait. Unable to make a clear diagnosis.  MRI was to be repeated in approx 6 mos Final Dx: ADEM vs MS.
within 24 hours after injection Pain at injection side, redness extending 7 inches by 4 inches; fever of 101 degrees orally; chills; severe weakness in arms and legs to the point of being unable to climb flight of stairs; severe nausea. I spoke to my doctor's NP. No treatment was indicated; I felt better the next day temp was down to 99.2 but my arm continued to be very red.
Patient received a 2nd dose of Pfizer bivalent 11 months after 1st dose, patient was not eligible for 2nd dose at time of administration.
This case was received from a health professional on 13 July 2007. A health professional reported that ten patients experienced "tingling sensation immediately after vaccination administration in arm", after receiving an injection of MENACTRA. The reporter stated that "it comes and go shortly". The events were reported as recovered. No additional information was provided.
Body aches with no pain in fingers; Pain in back; Pain in legs; Pain toes; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 09:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and allergy to antihistamines. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included lamotrigine (LAMICTAL), levetiracetam (KEPPRA), sertraline hydrochloride (ZOLOFT), lorazepam (ATIVAN) all for an unknown indication from an unknown date and unknown if ongoing.  On 07Mar2021 at 17:00, the patient experienced body aches with no pain in fingers and the main pain was back, legs and toes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, pain in back, legs and toes was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I got the first dose of Covid vaccine on 1/15 and starting on 1/20 started having arm/muscle pain on same arm. Then on 1/23 i noticed my arm was red/splotchy and very hot to the touch right below where i got the injection.   Covid vaccine 1/15/21  Several reactions Arm pain for a few days in deltoid-resolved 5 days later axilla sore-resolved 8 days later large area of dark redness on L deltoid around injection site - accompanied by mild dizziness- sxs lasted a few hours Currently feeling well Mild redness L upper arm No pain, no fever no systemic symptoms No mouth, tongue, throat swelling, no sob
This spontaneous report was received from a physician via a company representative, concerning a 6 month-old male patient. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On an unspecified date, the patient was vaccinated in error with a dose of VARIVAX route reported as injection (dose, frequency, lot # and expiration date were not reported) for prophylaxis. No adverse effect was reported. No product quality complaint (PQC) was involved. Additional information has been requested.